Mode
Text Size
Log in / Sign up

Sarcopenia

34 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Sarcopenia

47 trials tracked for Sarcopenia: 4 in phase 3 or 4 and 2 with published results. The most-cited published study has 75 citations.

47Trials tracked
4Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 3 Phase 2 11 Phase 1 3 Other / NA 29
  1. Phase 3 Starting a Testosterone and Exercise Program After Hip Injury Completed · 75 cited
  2. Phase 3 Effect Of Ophiochepalus Striatus Extract On Serum IGF-1 And IL-6 Levels In Elderly Patients With Sarcopenia Completed · 3 cited
  3. Phase 4 Anabolic and Inflammatory Responses to Short-Term Testosterone Administration in Older Men Completed
  4. Phase 3 Carnitine Supplementation and Skeletal Muscle Function Completed
  5. Phase 2 The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity Completed
  6. Phase 2 Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. Completed
Show 41 more trials
  1. Phase 2 Biological Effects of Weight Loss In Older, Obese Women Completed
  2. Phase 2 Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease Completed
  3. Phase 2 A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study Completed
  4. Phase 2 Dose Range Finding Study of Bimagrumab in Sarcopenia Completed
  5. Phase 2 A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005) Completed
  6. Phase 2 A Study of Muscle Strength Maintenance in Older Adults Completed
  7. Phase 2 A Double-blind, Placebo-controlled, Randomized INTerventional Clinical Trial (SARA-INT) Completed
  8. Phase 2 Trial of Oral Glutamine on Mitochondrial Function in CKD Completed
  9. Phase 2 5-Alpha Reductase and Anabolic Effects of Testosterone Completed
  10. Phase 1 Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals Completed
  11. Phase 1 Effect of a Ghrelin Receptor Agonist on Muscle and Bone Completed
  12. Phase 1 Ankle Assistance and Resistance in Older Adults Completed
  13. N/A The Impact of a Resistance Training Intervention on Blood Pressure Control in Older Adults With Sarcopenia Completed
  14. N/A Effect of an EAA/Whey Composition on Protein Metabolism Completed
  15. N/A Omega-3 Supplementation and Resistance Training Completed
  16. N/A The Efficacy of Aerobic Exercise Training on ANS and Endothelial Function in Compensated Cirrhosis Completed
  17. N/A Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer Completed
  18. N/A Study of the Long-term Effects of Exercise on Heath Indicators in Older People Completed
  19. N/A Blood Flow, Muscle Regeneration and Sarcopenia Completed
  20. N/A Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota in Sarcopenia Elderly Completed
  21. N/A Role of the Gut Microbiome on Lean Mass and Physical Function in Older Adults Completed
  22. N/A Resistance Exercise and Low-Intensity Physical Activity Breaks in Sedentary Time to Improve Muscle and Cardiometabolic Health Completed
  23. N/A Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults Completed
  24. N/A A Physical Activity Program in End-state Liver Disease Completed
  25. N/A Effect of Potassium Bicarbonate Supplementation on Bone and Muscle in Older Adults Completed
  26. N/A The Urinary Incontinence Treatment Study Completed
  27. N/A VR-based Rehabilitation in the Treatment and Prevention of Sarcopenia of Older Residents Completed
  28. N/A Time Course Adaptations Using Deuterated Creatine (D3Cr) Method Completed
  29. N/A Semi-Recumbent Vibration Therapy in Older Adults Completed
  30. N/A Integrated Physical Training With Protein Diet in Older Adults With Sarcopenia Symptoms. Completed
  31. N/A Identifying Therapeutic Targets of Accelerated Sarcopenia Completed
  32. N/A IMPACT: Inactivity Monitoring and Physical Activity Controlled Trial Completed
  33. N/A Nutritional Biomarkers of Sarcopenia Completed
  34. N/A Acetaminophen and Impaired Musculoskeletal Adaptations to Exercise Training Completed
  35. N/A Dietary Nitrate and Muscle Power With Aging Completed
  36. N/A Muscle Capillarization and Sarcopenia Completed
  37. N/A The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. Completed
  38. N/A Effects of a Resistance Training Program in Older Women With Sarcopenia Completed
  39. N/A Maximizing the Dietary Pattern of Older Adults: the Effects of Protein Intake on Protein Kinetics Completed
  40. N/A FrAilty Care and wEll-funcTion in Community Dwelling Older Adults Completed
  41. N/A Bingocize: A Novel Mobile Application for Older Adult Health Completed

Showing the 47 most-cited and recently-updated of 47 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Sarcopenia: what the trials found

Testosterone administration was evaluated for its impact on muscle mass and physical performance in patients with sarcopenia; however, no statistically significant changes were observed in 6-minute walk distance (p=0.853), total lean body mass (p=0.336), or appendicular lean body mass (p=0.934) 5. In a separate study, testosterone injection was associated with a reduction in global fatigue scores as measured by the Brief Fatigue Inventory 4.

Bimagrumab was evaluated across two trials for its effects on physical performance; neither trial showed significant improvements in Short Physical Performance Battery (SPPB) scores [12, 13] or 6-minute walk test (6MWT) distances [12, 13]. Additionally, bimagrumab did not significantly alter usual gait speed over 4 meters 13.

Recent results — preliminary, needs further review

  • * Yakult 300 LIGHT Fermented Milk was associated with significant improvements in sarcopenia markers, specifically handgrip strength (p=0.05) and walk speed (p=0.05), alongside changes in gut microbiota (p<0.05) 3. * Resistance exercise training showed statistically significant results regarding leg lean mass (p<0.01) and knee extension strength (p<0.01) 22. * Aerobic exercise combined with a nutrition consultant did not produce significant changes in time-domain or frequency-domain heart rate variability parameters 2. * Ankle resistance and biofeedback were investigated as an intervention 19. * Progressive resistance training was evaluated for sarcopenia management 1.

For the clinician treating this condition

  • Testosterone therapy did not demonstrate significant improvements in lean body mass or walking distance in clinical trials 5.
  • Bimagrumab did not result in statistically significant improvements in gait speed or 6-minute walk distances [12, 13].
  • Fermented milk (Yakult 300 LIGHT) showed potential for improving handgrip strength and walking speed in patients with sarcopenia 3.

AI synthesis of 8 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Sarcopenia

Can standard physical exam indicators accurately predict my sarcopenia risk?

Yes, standard physical exam indicators like calf circumference, BMI, and handgrip strength can predict sarcopenia risk with good accuracy, especially when combined in a validated model.

Full answer →
Does exercise lower TNF-alpha levels in older adults with sarcopenia?

Yes, exercise can lower TNF-alpha levels in older adults with sarcopenia, based on multiple clinical trials and meta-analyses.

Full answer →
Do specific plasma metabolites change in older patients with sepsis and sarcopenia?

Yes, older patients with sepsis and sarcopenia show distinct plasma metabolomic changes, including altered amino acid, lipid, and steroid pathways, compared to those without sarcopenia.

Full answer →
Does obstructive sleep apnea increase my risk of developing sarcopenia?

Yes, research suggests obstructive sleep apnea (OSA) is linked to a higher risk of sarcopenia, with meta-analyses showing about 85% increased odds, though the exact mechanisms are still being studied.

Full answer →

All Sarcopenia Articles